Strides Arcolab receives 2nd injectable ANDA approval for Tobramyc

Subscribe to Oneindia News

New Delhi, Mar 12 (UNI) Strides Arcolab Ltd today announced its second Abbreviated New Drug Application (ANDA) approval for Tobramycin 40 mg/mL.

The product is licensed to Akorn-Strides, LLC, which is a Joint Venture that was formed in 2004 by Akorn, Inc and Strides Arcolab Ltd.

Tobromycin is the second approval amongst 22 sterile submissions the company has submitted with US FDA.

UNI BJR PBB RN1458

Please Wait while comments are loading...